The outcome of patients diagnosed with uveal metastases from breast carcinoma, all of whom were treated with one of the new generation of hormone therapies named aromatase inhibitors, is reported.
Oncology Service, Wills Eye Hospital, Thomas-Jefferson University, University of Pennsylvania, Philadelphia, Pennsylvania 19107, USA. m_manquez@yahoo.com
